Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Maternal Choline Supplements for Prenatal Cannabis Exposure
NCT06379971Phase 1Recruiting
- Sponsor
- University of Colorado Denver
- Start
- Nov 2024
- Primary completion
- Apr 2029
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial comparing Placebo with Phosphatidylcholine (2 arms). Primary endpoints: Infant Behavior Questionnaire-Revised Orienting/Regulation Index and Auditory Sensory Gating (P50). Started Nov 2024; status: recruiting.
02
Drugs
phosphatidylcholine
Beyond the preview
Go deeper on NCT06379971.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06379971.